We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.65B
Cap. Flow
% of AUM
97.21%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$91.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$79.7M |
| 3 |
Apple
AAPL
|
+$78.2M |
| 4 |
Qualcomm
QCOM
|
+$73.5M |
| 5 |
Amgen
AMGN
|
+$71.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 8.01% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Timken Company
TKR
$9.82B
| $4.4M | 0.09% |
+103,000
| New | +$4.33M |
|
252
Nasdaq
NDAQ
$51.5B
| $4.37M | 0.09% |
+273,456
| New | +$4.02M |
|
253
Teva Pharmaceuticals
TEVA
$35.9B
| $4.35M | 0.09% |
+75,701
| New | +$4.22M |
|
|
TWC
254
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $4.32M | 0.09% |
+28,411
| New | +$4.1M |
|
|
TFCFA
255
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $4.25M | 0.09% |
+110,688
| New | +$3.92M |
|
256
Banco Bradesco
BBD
$38.1B
| $4.18M | 0.09% |
+798,478
| New | +$4.47M |
|
257
KLA
KLAC
$275B
| $4.16M | 0.09% |
+591,850
| New | +$4.37M |
|
|
KYTH
258
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $4.16M | 0.09% |
+120,000
| New | +$4.19M |
|
259
Devon Energy
DVN
$51.9B
| $4.15M | 0.09% |
+67,827
| New | +$4.11M |
|
|
KITE
260
DELISTED
Kite Pharma, Inc.
KITE
| $4.15M | 0.09% |
+72,000
| New | +$3.03M |
|
261
Republic Services
RSG
$66.7B
| $4.05M | 0.08% |
+100,553
| New | +$3.94M |
|
262
Omeros
OMER
$709M
| $4.01M | 0.08% |
+161,795
| New | +$2.95M |
|
263
Suncor Energy
SU
$77.7B
| $4M | 0.08% |
+125,502
| New | +$4.15M |
|
264
Ford
F
$57.3B
| $3.98M | 0.08% |
+256,519
| New | +$3.78M |
|
|
INFI
265
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $3.97M | 0.08% |
+235,000
| New | +$3.42M |
|
266
AutoZone
AZO
$48.3B
| $3.96M | 0.08% |
+6,401
| New | +$3.61M |
|
267
Bausch Health
BHC
$1.65B
| $3.95M | 0.08% |
+27,576
| New | +$3.71M |
|
|
DYAX
268
DELISTED
DYAX CORPORATION
DYAX
| $3.94M | 0.08% |
+280,000
| New | +$3.5M |
|
|
VIAB
269
DELISTED
Viacom Inc. Class B
VIAB
| $3.92M | 0.08% |
+52,061
| New | +$3.8M |
|
|
ANAC
270
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $3.87M | 0.08% |
+120,000
| New | +$3.6M |
|
271
Baxter International
BAX
$11.6B
| $3.87M | 0.08% |
+97,174
| New | +$3.78M |
|
272
eBay
EBAY
$48.6B
| $3.86M | 0.08% |
+163,447
| New | +$3.71M |
|
|
WWAV
273
DELISTED
The WhiteWave Foods Company
WWAV
| $3.85M | 0.08% |
+110,000
| New | +$3.9M |
|
|
GHDX
274
DELISTED
Genomic Health, Inc.
GHDX
| $3.84M | 0.08% |
+120,000
| New | +$3.91M |
|
275
Omnicom Group
OMC
$22.7B
| $3.77M | 0.08% |
+48,731
| New | +$3.55M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
- Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
- Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.
Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.